issued shares in Indo Rama Synthetics (India) Limited (“IRSL”), equaling to approximately 31.79% of IRSL’s enlarged share capital (the “Share Purchase”) at the price of INR 36 per share. The Company would

by its indirect subsidiary Indorama Netherlands B.V. (“INBV”) of 83,000,000 newly issued shares in Indo Rama Synthetics (India) Limited (“IRSL”), equaling to approximately 31.79% of IRSL’s enlarged

or 22.90% over the same period of last year of which hospital revenues totally raised by 10.16% along with the enlarged customer base of Subsidiary (AMARC) showing 15.67% of revenues’ growth. In

year, the Company has not yet earned income from Excellence Center (New Building) planned to official grand opening in the following year of February 2018) along with the enlarged customer base of the

shareholders, and subscribe Phoenix’s newly issued shares of 180.00 million shares, totaling 314.60 million shares or 55 percent of total enlarged shares of Phoenix. List of shareholders before and after

performance in 2nd quarter and 6-month period, its cost of services amounted to Baht 21.3 million and Baht 45.4 million, a rise of 12.4% and 20.5% whereas its selling & administrative expenses enlarged at

included sales of investment in Mae Sod Clean Energy Co., Ltd. of 59.10MB while sales of investment in PDIL of 50.10MB was included in 9M 2016. The company marked remarkable progress in its make-over

Solutions (CIS) and Networking Power along with the remarkable growth of Electric Vehicle Solutions in the second half of this year Gross profit of this quarter amounted to Baht 4,574 million, went up 92.8

. Gross profit of this quarter totaled 4,103 million baht, boost up 58.7% from the same quarter of last year driven by sales revenue remarkable growth for the 4th consecutive quarter from the aforementioned

considered a positive factor that shall enable the Company's operating performance to grow continually in the future. 2019 was considered the year that the Company had a remarkable performance and achieved the